HOME » INVESTORS: NEWS RELEASES
2004 NEWS RELEASES
December 8, 2004 (PDF) -
MIGENIX Reports Second Quarter Fiscal Year 2005 Financial Results
November 18,
2004 (PDF) - MIGENIX Appoints Recognized Financial Market Expert, W.
Keith Schilit, Ph.D. to Board
November 9,
2004 (PDF) - MIGENIX Presents Data Supporting Efficacy of MX-4565 in
Retinitis Pigmentosa
October 27, 2004 (PDF) -
MIGENIX to Present at the Rodman & Renshaw Techvest 6th Annual Healthcare
Conference on October 27th
October 13,
2004 (PDF) - MIGENIX Initiates Hepatitis C Phase II Clinical Study
September 21,
2004 (PDF) - MIGENIX Inc. Completes Name Change with New Trading
Symbol: MGI
September 9, 2004
(PDF) - Micrologix Reports First Quarter Fiscal Year 2005 Financial Results -
Name Change to MIGENIX Inc. Reflects Transformation
September 7,
2004 (PDF) - Micrologix Receives Approval to Initiate Phase II Study
of MBI-3253 (celgosivir) in Hepatitis C Patients - Results Expected Q2 Calendar
2005 from Multi-center, Monotherapy Study
August 31,
2004 (PDF) - Micrologix Completes MitoKor Acquisition
August 16,
2004 (PDF) - Micrologix Receives Permit from State of California To
Proceed with MitoKor Acquisition
August 3,
2004 (PDF) - Micrologix and Strata Pharmaceuticals Complete License
Agreement for MBI-226
July 20,
2004 (PDF) - MBI-3253 (celgosivir) Demonstrates Potent Activity
Against Hepatitis C Virus Surrogate
July 12,
2004 (PDF) - Micrologix Reports Fourth Quarter and Fiscal Year 2004
Financial Results
June 3,
2004 (PDF) - Micrologix Enters Into Exclusive License Negotiation
Period to Partner MBI-226
April 15,
2004 (PDF) - Micrologix To Acquire San Diego-based MitoKor, Inc. -
Acquisition Adds Clinical and Preclinical Product Candidates in Alzheimer’s
Disease, Arthritis, and Other Large-Market Indications
March 11,
2004 (PDF) - Micrologix Reports Third Quarter Fiscal Year 2004
Financial Results
March 8, 2004
(PDF) - Micrologix Completes $6.75 Million Offering
February 19,
2004 (PDF) - Micrologix Enters Into Firm Underwriting
for up to $7.5 Million Offering
February 3,
2004 (PDF) - Micrologix Acquires Clinical-Stage Hepatitis C Drug
Candidate
January 21, 2004
(PDF) - Micrologix Meets With FDA On MBI-226
|
